Molecular diagnostics and NSCLC management

被引:0
|
作者
不详
机构
关键词
D O I
10.1111/ajco.12196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 1
页数:1
相关论文
共 50 条
  • [1] Racial and Socioeconomic Disparities in Molecular Diagnostics for NSCLC Patients
    Tuminello, S. J.
    Untalan, M.
    Ivic-Pavlicic, T.
    Turner, W.
    Flores, R.
    Taioli, E.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S171 - S171
  • [2] Racial and socioeconomic disparities in molecular diagnostics for NSCLC patients
    Tuminello, Stephanie
    Turner, Wiley
    Untalan, Matthew
    Flores, Raja
    Taioli, Emaneula
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [3] Molecular diagnostics in the management of rhabdomyosarcoma
    Arnold, Michael A.
    Barr, Fredric G.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (02) : 189 - 194
  • [4] Pathology as gatekeeper. New histopathological classification of NSCLC and molecular diagnostics
    Petersen, I.
    Fisseler-Eckhoff, A.
    Warth, A.
    Weichert, W.
    ONKOLOGE, 2014, 20 (10): : 933 - +
  • [5] Molecular diagnostics in advanced NSCLC: Trying to maximize a non-ideal situation
    Lim, Elaine H.
    Tan, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 782 - 782
  • [6] Management of Gene Promoter Mutations in Molecular Diagnostics
    de Vooght, Karen M. K.
    van Wijk, Richard
    van Solinge, Wouter W.
    CLINICAL CHEMISTRY, 2009, 55 (04) : 698 - 708
  • [7] Modern molecular diagnostics and the management of haematological malignancies
    Morgan, GJ
    Pratt, G
    CLINICAL AND LABORATORY HAEMATOLOGY, 1998, 20 (03): : 135 - 141
  • [8] The Role of Molecular Diagnostics in the Management of Patients with Gliomas
    Wirsching, Hans-Georg
    Weller, Michael
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (10)
  • [9] Better Anaphylaxis Management thanks to molecular Diagnostics
    Freyer, Martina
    ALLERGO JOURNAL, 2014, 23 (06) : 102 - 102
  • [10] The Role of Molecular Diagnostics in the Management of Patients with Gliomas
    Hans-Georg Wirsching
    Michael Weller
    Current Treatment Options in Oncology, 2016, 17